Skip to main content
. 2018 Mar 14;17(5):6969–6976. doi: 10.3892/mmr.2018.8741

Figure 2.

Figure 2.

Analysis the efficacy of Tan-IIA on bone-resorbing activity and apoptosis of osteoclasts. (A) Apoptotic index of osteoblasts induced by RANKL following treatment with Tan-IIA, ADN or PBS. (B) Relative mRNA levels of caspase-3 in osteoblasts. (C) Relative mRNA levels of Apaf-1 in osteoblasts. (D) Gene expression levels of anti-apoptotic Bcl-2 in osteoblasts. (E) Gene expression levels of anti-apoptotic p53 in osteoblasts. (F) Bone resorbing activity of osteoblasts following treatment with Tan-IIA, ADN or PBS. Data are presented as the mean ± standard error of the mean. **P<0.01. ADN, alendronate; Tan-IIA, tanshinone IIA; RANKL, receptor activator of NF-κB ligand; Apaf-1, apoptotic protease-activating factor 1; Bcl-2, B-cell lymphoma 2.